Source: State of Delaware, Division of Public Health, Delaware Health Statistics Center, 2012

CDC. MMWR 2011. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm60e1101a1.htm?s_cid=mm60e1101a1_w. Updated with 2009 mortality and 2010 treatment admission data.

Prescription Drug Action Committee

Delaware: 9th highest drug overdose death rate (2009)◦ DE average deaths per 100,000 population: 10.5◦ National average deaths per 100,000: 12.0◦ Drug overdose death rate increased 142% (1999-2009)

More Delaware residents 12 and older report using non-medical use of opioid pain relievers◦ DE average: 5.6%◦ National average: 4.8%

Substance abuse treatment admission rates for opioids increased over 2,750% (1999-2010)

Delaware 5th highest for opioid sales (2010)◦ DE average: 10.2 KG per 100,000 population◦ National average: 7.1 KG per 100,000 population

National Vital Statistics System, 2008; Automated Reports Consolidated Orders System, 2010.

Kg of opioid pain relievers used per 10,000

Age-adjusted rate per 100,000

Under treatment of pain

Increasing availability of opioid analgesics

Increase in abuse of prescription opioids

Ling ppt, 2005

Pain scale

Pain as a vital sign

History and Accomplishment Established in February 2012 by Governor

Markell. Focused on coordinating public, private and

community efforts under the leadership of the Division of Public Health and the Medical Society of Delaware.

The PDAC has a broad and diverse membership. To date, PDAC has conducted over 15 full

committee public meetings and over 45 sub committee meetings.

• Require all prescribers with a controlled substance registration and pharmacists to complete 2 hours of continuing education training. Two hours of prescriber training will focus on safe and effective prescribing methods. For Pharmacists, training will focus on recognizing patient abuse seeking behaviors.

• Require controlled substance prescribers to take a one hour, one time only CME on Delaware specific prescription drug abuse and pain management topics to include: the Prescription Monitoring Program (PMP), Delaware Regulation 31 and other state specific programs and policies.

• Standardize continuing education of law enforcement regarding controlled substance related abuse and impairment.   

• Require hospice agencies to implement a uniform procedure to dispose of controlled substances after a patient passes away.

• Require practitioners with controlled substance licenses to register for access to the Prescription Monitoring Program (PMP).

• Enable provider authorized support staff to delegate access to the PMP via their own log-in identification and password.

• Require substance abuse treatment centers to use the PMP to evaluate patient risk of abuse.

• Require pharmacists to obtain a Prescription Monitoring Program (PMP) patient profile when there is a suspicion of abuse seeking behaviors.

• Eliminate the 72 hour exemption for reporting dispensing of controlled substances to the PMP.

• Launch a statewide public education and outreach campaign based upon the successful school nurse partnership.

• Ensure that chronic pain patients have safe and consistent access to care and support provider education by increasing access to pain management and substance abuse experts.

• Integrate multiple data sources to develop a robust surveillance system.

• Implement Electronic Prescribing for Controlled Substances.

• Implement long term drug take-back solution; federal guidance expected late 2013.

• Implement a pilot program for BLS to use Narcan.

PDAChttp://dhss.delaware.gov/dhss/dph/pdachome.html